首页 > 市场调查报告书 > 医疗设备

导管心血管设备

全球经导管心臟瓣膜市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

市场调查报告书

商品编码

1421065

全球经导管心臟瓣膜市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Transcatheter Heart Valve Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 131 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球经导管心臟瓣膜市场需求预计将从 2023 年的 61.2 亿美元增至 2032 年的近 237.9 亿美元，2024-2032 年研究期间CAGR为 16.29%。

经导管心臟瓣膜（THV）是一种用于经导管主动脉瓣置换术（TAVR）或经导管主动脉瓣植入术（TAVI）的医疗器材。与传统的心臟直视手术相比，这是一种侵入性较小的治疗主动脉瓣狭窄的替代方案，主动脉瓣狭窄是指主动脉瓣变窄，限制心臟血流的疾病。

市场动态

经导管心臟瓣膜（THV）市场受到多种因素的推动，包括全球人口老化，与年龄相关的心臟瓣膜疾病变得越来越普遍。微创手术的吸引力是一个重要的驱动因素，经导管主动脉瓣置换术 (TAVR) 提供了心臟直视手术的更好替代方案。不断的技术进步提高了经导管心臟瓣膜的功效，改进的设计和材料有助于更好的结果。人们越来越认识到这些手术的好处，加上心血管疾病发生率的上升，推动了市场的成长。有利的报销政策、医疗实体之间的合作以及旨在加强医疗基础设施的政府倡议也发挥着关键作用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球经导管心臟瓣膜市场的各个细分市场进行了包容性评估。经导管心臟瓣膜产业的成长和趋势为本研究提供了整体方法。

市场区隔

经导管心臟瓣膜市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按应用

经导管主动脉瓣
经导管肺动脉瓣
经导管二尖瓣

依技术

球囊扩张经导管瓣膜
自膨胀式经导管瓣膜

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲经导管心臟瓣膜市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。经导管心臟瓣膜市场的主要参与者包括波士顿科学公司、Bracco Group、Braile Biomedica、Direct Flow Medical、Edwards Lifesciences、JenaValve、St. Jude Medical、Symetis、ValveXchange Inc。本节包括竞争格局的整体视图其中包括各各模式种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：经导管心臟瓣膜公司的竞争格局

经导管心臟瓣膜市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Bracco Group

公司简介
公司收入
产品
最近的发展

Braile Biomedica

公司简介
公司收入
产品
最近的发展

Direct Flow Medical

公司简介
公司收入
产品
最近的发展

Edwards Lifesciences

公司简介
公司收入
产品
最近的发展

JenaValve

公司简介
公司收入
产品
最近的发展

St. Jude Medical

公司简介
公司收入
产品
最近的发展

Symetis

公司简介
公司收入
产品
最近的发展

ValveXchange Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113300

The global demand for Transcatheter Heart Valve Market is presumed to reach the market size of nearly USD 23.79 BN by 2032 from USD 6.12 BN in 2023 with a CAGR of 16.29% under the study period 2024 - 2032.

Transcatheter heart valve (THV) is a medical device used in transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI). It's a less invasive alternative to traditional open-heart surgery for treating aortic valve stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart.

MARKET DYNAMICS

The transcatheter heart valve (THV) market is propelled by various factors, including the aging global population, where age-related heart valve diseases are becoming more prevalent. The appeal of less invasive procedures is a significant driver, with Transcatheter Aortic Valve Replacement (TAVR) offering a preferable alternative to open-heart surgery. Continuous technological advancements enhance the efficacy of transcatheter heart valves, with improved designs and materials contributing to better outcomes. Increasing awareness about the benefits of these procedures, coupled with rising cardiovascular disease incidences, fuels the market growth. Favorable reimbursement policies, collaborations between medical entities, and government initiatives aimed at enhancing healthcare infrastructure also play pivotal roles.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transcatheter heart valve. The growth and trends of transcatheter heart valve industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the transcatheter heart valve market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve

By Technology

Balloon Expanded Transcatheter Valve
Self-Expanded Transcatheter Valve

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transcatheter Heart Valve market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transcatheter Heart Valve market include Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . TRANSCATHETER HEART VALVE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Transcatheter Aortic Valve Historic and Forecast Sales by Regions
5.5 Transcatheter Pulmonary Valve Historic and Forecast Sales by Regions
5.6 Transcatheter Mitral Valve Historic and Forecast Sales by Regions

6 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Balloon Expanded Transcatheter Valve Historic and Forecast Sales by Regions
6.5 Self-Expanded Transcatheter Valve Historic and Forecast Sales by Regions

7 . GLOBAL TRANSCATHETER HEART VALVE MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE TRANSCATHETER HEART VALVE COMPANIES

8.1. Transcatheter Heart Valve Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF TRANSCATHETER HEART VALVE INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Boston Scientific Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Bracco Group
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Braile Biomedica
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Direct Flow Medical
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Edwards Lifesciences
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. JenaValve
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. St. Jude Medical
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Symetis
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. ValveXchange Inc.
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments